Erratum to “Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn’s disease patients” [Heliyon 9(4) (April 2023) e14594]

Detalles Bibliográficos
Autores principales: Zhu, Chao, Wang, Xingwei, Wang, Shihui, Hu, Jing, Gao, Yankun, Li, Cuiping, Li, Jianying, Wu, Xingwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360538/
https://www.ncbi.nlm.nih.gov/pubmed/37484401
http://dx.doi.org/10.1016/j.heliyon.2023.e16573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360538/
https://www.ncbi.nlm.nih.gov/pubmed/37484401
http://dx.doi.org/10.1016/j.heliyon.2023.e16573

Ejemplares similares